The Human Gut-Liver-Axis In Health And Disease
Aleksander Krag, Torben Hansen
Published 2019 ·
Download PDFAnalyze on Scholarcy
This paper references
Incidence, etiology and mortality of cirrhosis: a population-based cohort study
A D Fialla (2012)
Transient elastography for the diagnosis of liver fibrosis: a systematic review of economic evaluations.
Sasha van Katwyk (2017)
Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop.
Arun J Sanyal (2015)
The effect of acute
Evolution of non - invasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C
J Vergniol (2014)
Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.
Morten Asser Karsdal (2015)
The effect of acute alcohol intoxication on gut wall integrity in healthy male volunteers; a randomized controlled trial.
Wilfried de Jong (2015)
The Utility of Commonly Used Laboratory Tests to Screen for Excessive Alcohol Use in Clinical Practice.
Gina Gough (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri (2015)
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis.
Asociacion Latinoamericana para el Estudio del Higado (2015)
Dietary saturated lipids in alcoholic liver disease: new microbiota-targeting bullets?
Herbert Tilg (2015)
Histopathology of alcoholic liver disease.
Neil D. Theise (2013)
Effect of abstinence from alcohol on survival of patients with alcoholic cirrhosis: A systematic review and meta-analysis.
Yan-di Xie (2014)
Alcoholic liver disease: mechanisms of injury and targeted treatment
Alexandre Louvet (2015)
Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
Emily Cohen (2007)
Global burden of alcoholic liver diseases.
Jürgen Rehm (2013)
Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar.
M. A. Karsdal (2014)
Causes of Death in People with Liver Cirrhosis in England Compared with the General Population: A Population-Based Cohort Study
S Ratib (2015)
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin
Francesca Romana Ponziani (2016)
Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis.
Maja Thiele (2016)
Gut microbiome and liver diseases
Herbert Tilg (2016)
Non-invasive diagnosis of hepatic steatosis
Christiane Stern (2016)
Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
Raymond Kwok (2015)
Colonic microbiome is altered in alcoholism.
Ece A. Mutlu (2012)
Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study.
Peter Jepsen (2010)
Alcohol dependence and risk of somatic diseases and mortality: a cohort study in 19 002 men and women attending alcohol treatment
Charlotte Holst (2017)
The relationship between different dimensions of alcohol use and the burden of disease—an update
Jürgen Rehm (2017)
Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study.
Edith M. Koehler (2016)
Clinical impact of alcohol-related cirrhosis in the next decade: estimates based on current epidemiological trends in the United States.
John Guirguis (2015)
Critical comparison of elastography methods to assess chronic liver disease
Mireen Friedrich-Rust (2016)
Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence.
Fabienne Pessione (2003)
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Matthew James Armstrong (2016)
The clinical use of HVPG measurements in chronic liver disease
Jaume Bosch (2009)
Decompensated alcohol related liver disease: acute management
Stuart McPherson (2016)
Liver disease in the UK: a Lancet Commission
Roger Williams (2013)
Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients
Marcelo Soto (2017)
Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease
Moisès Llopis (2015)
Acute Binge Drinking Increases Serum Endotoxin and Bacterial DNA Levels in Healthy Individuals
Shashi Bala (2014)
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
C. S. Ripoll (2007)
The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate.
Anthea J. Palmer (2000)
Gut-liver axis in alcoholic liver disease.
Gyongyi Szabo (2015)
Heavy daily alcohol intake at the population level predicts the weight of alcohol in cirrhosis burden worldwide.
Eva Kristin Stein (2016)
Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C.
Julien Vergniol (2014)
Hepatic steatosis: innocent bystander or guilty party?
Christopher Paul Day (1998)
Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.
Roberto de Franchis (2015)
Cirrhosis improvement to alcoholic liver fibrosis after passive abstinence
Hideaki Takahashi (2014)
Evaluation of work-based screening for early signs of alcohol-related liver disease in hazardous and harmful drinkers: the PrevAIL study
Penny A Cook (2015)
Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.
Charles S. Lieber (2004)
Transient Elastography for Diagnosis of Stages of Hepatic Fibrosis and Cirrhosis in People with Alcoholic Liver Disease
Chavdar S. Pavlov (2017)
Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
Jasmohan S Bajaj (2013)
Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study.
Gro Askgaard (2015)
Intestinal fungi contribute to development of alcoholic liver disease
An-Ming Yang (2017)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
David E Kleiner (2005)
Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies
Carole Hart (2010)
Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients.
Gennaro D'Amico (2014)
Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia
Li Xue (2017)
Rates and predictors of relapse after natural and treated remission from alcohol use disorders.
Rudolf H. Moos (2006)
Targeting the gut-liver axis in liver disease.
Roberto Wiest (2017)
Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - a randomized open-label controlled study.
Moon Young Kim (2012)
Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota.
Sena Bluemel (2016)
Alcohol and liver disease in Europe--Simple measures have the potential to prevent tens of thousands of premature deaths.
Nick Sheron (2016)
microbiome and liver diseases
Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.
Daniel E. Jonas (2014)
Inflammasome activation and function in liver disease
Gyongyi Szabo (2015)
Effect of policy, economics, and the changing alcohol marketplace on alcohol related deaths in England and Wales
Nick Sheron (2016)
Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease.
Carolin Lackner (2017)
Effect of detoxification on liver stiffness assessed by Fibroscan® in alcoholic patients.
Eve Gelsi (2011)
Drinking habits as cofactors of risk for alcohol induced liver damage
Stefano Bellentani (1997)
Gut Microbiota, Cirrhosis, and Alcohol Regulate Bile Acid Metabolism in the Gut
Jason M. Ridlon (2015)
Detlef Schuppan (2008)
Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study.
Thomas Deleuran (2012)
Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: a nationwide population based cohort study.
Thomas Damgaard Sandahl (2011)
The genetics of alcohol dependence and alcohol-related liver disease.
Felix Stickel (2017)
Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis.
Jürgen Rehm (2010)